NICE issues new guidelines on Ritalin
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7269.1100 (Published 04 November 2000) Cite this as: BMJ 2000;321:1100- Roger Dobson
- Abergavenny
New guidelines from the National Institute for Clinical Excellence (NICE) for the use of methylphenidate in England and Wales advise that the drug should be used as part of a comprehensive treatment programme for children with a diagnosis of severe attention deficit hyperactivity disorder.
In its latest guidance, the institute said that an estimated 1% of school aged children—69 000 children aged 6 to 16 in England and 4200 in Wales—meet the diagnostic criteria for severe, “combined-type” attention deficit …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.